"Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study." by Goran B.G. Klintmalm

Selected Works of Thomas Heffron, MD, FACS

Article

Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study.

Liver Transplantation (2007)

Goran B.G. Klintmalm, Baylor University Medical Center
W. Kenneth Washburn, University of Texas Health Science Center at San Antonio
Steven M. Rudich, University of Cincinnati
Thomas G. Heffron, Emory University
Lewis W. Teperman, New York University
Carlos Fasola, Emory University
Devin E. Eckhoff, University of Alabama at Birmingham
George J. Netto, Johns Hopkins University
Eliezer Katz, CTI Clinical Trial and Consulting Services

Link

Disciplines

Publication Date

November 1, 2007

DOI

10.1002/LT.21182

Citation Information

Goran B.G. Klintmalm, W. Kenneth Washburn, Steven M. Rudich, Thomas G. Heffron, et al.. "Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study." Liver Transplantation Vol. 13 Iss. 11 (2007) p. 1521 - 1531
Available at: http://works.bepress.com/thomas-heffron/10/